Holen Sie sich die Stockscreener-App
162.05
0.12%
0.20
Handel nachbörslich:
162.05
Icon Plc Aktie (ICLR) Neueste Nachrichten
Hybrid Clinical Research Associate Job at ICON | Apply Online Here - BioTecNika
UBS Restarts Coverage of Icon PLC (ICLR) with Neutral Rating and $195 Price Target - GuruFocus
Hybrid Clinical Research Job Opening at ICON plc | Apply Online Here - BioTecNika
A Look at Icon PLC (ICLR) After 6.1% Gain -- GF Value $205.79 vs Price $173.90 - GuruFocus
ICON Plc (ICLR) Rises as Investors Appear to Lean on Backlog, Guidance, and Recent Filings - Moomoo
ICON plc (ICLR) rises as investors appear to lean on backlog, guidance, and recent filings - Quiver Quantitative
ICON Public Limited Company’s (ICLR) Shrinking Moat Warranted an Early Departure - Yahoo Finance
Icon PLC (ICLR) Stock Up 3.3% and Still Undervalued -- GF Score: 95/100 - gurufocus.com
Rare Disease Contract Research Organization (CRO) Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook - GlobeNewswire Inc.
ICON plc stock edges higher after analyst updates and steady Q2 figures - AD HOC NEWS
Icon PLC (ICLR) Stock Down 3.3% -- Now Undervalued? GF Score: 96/100 - GuruFocus
Citi Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $175 - Moomoo
ICLR Maintained by Citigroup -- Price Target Lowered to $175 - GuruFocus
Strategic Sale: DR JOHN CLIMAX Decides To Exercise Options Worth $204K At Icon - Benzinga
ICON PLC Director Eugene McCague Exercises Stock Options and Sells Shares on September 17, 2026 - kalkinemedia.com
S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag - Barron's
Icon (ICLR) insider sells 5,005 shares after exercising options - Stock Titan
Director at ICON (ICLR) unloads stock right after exercising options - Stock Titan
Director at ICON (NASDAQ: ICLR) exercises options, then sells 5,005 shares - Stock Titan
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating - Moomoo
ICON PLC (NASDAQ: ICLR) director plans 569,625 stock sale - Stock Titan
ICON (NASDAQ: ICLR) director plans to sell thousands of shares in 2026 - Stock Titan
ICON plc Q2 2026 Earnings: EPS Narrowly Misses Estimate as Stock Edges LowerProduct Revenue Analysis - careplusvn.com
ICON plc (NASDAQ: ICLR) director plans $876K sale after $138K trade - Stock Titan
ICON plcOrdinary Shares (Nasdaq:ICLR) Detailed Stock Data - The Chronicle-Journal
ICON plc (ICLR) Stock Analysis: Unpacking a 9.6% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
ICON plc Stock Price: ICLR Stock Chart, Market Cap & News Today - CoinGecko
A Look at Icon PLC (ICLR) After 3.9% Gain -- GF Value $207.68 vs Price $165.69 - GuruFocus
ICON PLC (NASDAQ: ICLR) Releases Unaudited Interim Financial Statements in September 9 Filing - kalkinemedia.com
ICON taps Anthropic and Microsoft as it puts clinical-trial agents into production - R&D World
[6-K] ICON PLC Current Report (Foreign Issuer) - Stock Titan
Is Icon PLC (ICLR) a Bargain After 4.1% Drop? GF Value Says Unde - GuruFocus
ICON plc (ICLR) Stock Report: Evaluating a 12.56% Potential Upside Amidst Healthcare Sector Expansion - DirectorsTalk Interviews
Long term debt to total equity ratio of ICON Plc – HAM:IJF - TradingView
Icon plc stock holds steady as Q2 2026 results support full-year guidance - ad-hoc-news.de
ICON Plc (ICLR) Stock Analysis: Exploring Growth Potential With A 9.14% Upside - DirectorsTalk Interviews
How ICON’s Mixed Q1 Earnings and Reaffirmed 2026 Outlook Could Impact ICON (ICLR) Investors - sahmcapital.com
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Icon (ICLR) Stock Forecast and Price Target 2026 $ICLR - MarketBeat
ICON plc (ICLR) Stock Analysis: Navigating Growth in Diagnostics & Research with a 7.74% Upside - DirectorsTalk Interviews
ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability - BioSpace
ICON plc (ICLR) posts top-1% ESG score and 73% emissions cut - Stock Titan
A Look at Icon PLC (ICLR) After 3.2% Gain -- GF Value $208.22 vs Price $172.49 - GuruFocus
ETFs Investing in ICON Plc Stocks - TradingView
ICON plc (NASDAQ: ICLR) swaps secured loans for $2.15B in new notes - Stock Titan
White & Case advises ICON on its US$2.15 billion notes offering and related secured debt refinancing - White & Case LLP
6-K: Icon PLC | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Icon PLC (ICLR) Shares Surge 3.9% -- What GF Score of 93 Tells I - GuruFocus
ICON plc (ICLR) Stock Analysis: Strong Buy Ratings and 13.74% Potential Upside Highlight Investment Appeal - DirectorsTalk Interviews
Icon CEO awarded $3.7m in shares as company emerges from turmoil - Irish Independent
Does ICON’s Shift to an Unsecured Capital Structure Reshape the Bull Case for ICLR? - Sahm
Icon Plc $ICLR Shares Bought by Handelsbanken Fonder AB - MarketBeat
Invesco Ltd. (ICLR) discloses 6.9% beneficial stake in ICON PLC - Stock Titan
Director Of Icon Makes $138K Sale - Benzinga
ICON plc (ICLR) Rises 0.96% to $167.17 on Steady CRO Sector DemandInstitutional Buy Signals - vinanet.vn
Trinity Street Asset Management LLP Raises Stock Position in Icon Plc $ICLR - MarketBeat
ICON PLC (ICLR) director logs RSU vesting, new grant and tax sell-to-cover trades - Stock Titan
ICON plc (ICLR) director’s RSU vesting triggers tax-related share sales - Stock Titan
ICON PLC (ICLR) director sells 2,677 shares, receives new 2,047 RSU grant - Stock Titan
0.97%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):